These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22623228)

  • 1. Identification of C(6) -ceramide-interacting proteins in D6P2T Schwannoma cells.
    Kota V; Szulc ZM; Hama H
    Proteomics; 2012 Jul; 12(13):2179-84. PubMed ID: 22623228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid 2-hydroxylase regulates cAMP-induced cell cycle exit in D6P2T schwannoma cells.
    Alderson NL; Hama H
    J Lipid Res; 2009 Jun; 50(6):1203-8. PubMed ID: 19171550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the immunobiology of ceramide.
    Pandey S; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2007 Jun; 82(3):298-309. PubMed ID: 17045585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of ceramide in coordinating cellular responses to stress.
    Hannun YA
    Science; 1996 Dec; 274(5294):1855-9. PubMed ID: 8943189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceramide-1-Phosphate Is Involved in Therapy-Induced Senescence.
    Millner A; Running L; Colon-Rosa N; Aga DS; Frasor J; Atilla-Gokcumen GE
    ACS Chem Biol; 2022 Apr; 17(4):822-828. PubMed ID: 35353506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assaying Ceramide Synthase Activity In Vitro and in Living Cells Using Liquid Chromatography-Mass Spectrometry.
    Lim XY; Pickford R; Don AS
    Methods Mol Biol; 2016; 1376():11-22. PubMed ID: 26552671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in determining signaling mechanisms of ceramide and role in disease.
    Stith JL; Velazquez FN; Obeid LM
    J Lipid Res; 2019 May; 60(5):913-918. PubMed ID: 30846529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas.
    Koybasi S; Senkal CE; Sundararaj K; Spassieva S; Bielawski J; Osta W; Day TA; Jiang JC; Jazwinski SM; Hannun YA; Obeid LM; Ogretmen B
    J Biol Chem; 2004 Oct; 279(43):44311-9. PubMed ID: 15317812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular signal transduction pathways activated by ceramide and its metabolites.
    Ruvolo PP
    Pharmacol Res; 2003 May; 47(5):383-92. PubMed ID: 12676512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric identification of increased C16 ceramide levels during apoptosis.
    Thomas RL; Matsko CM; Lotze MT; Amoscato AA
    J Biol Chem; 1999 Oct; 274(43):30580-8. PubMed ID: 10521441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide regulates cellular homeostasis via diverse stress signaling pathways.
    Ruvolo PP
    Leukemia; 2001 Aug; 15(8):1153-60. PubMed ID: 11480555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells.
    Gopalan A; Yu W; Jiang Q; Jang Y; Sanders BG; Kline K
    Mol Nutr Food Res; 2012 Dec; 56(12):1803-11. PubMed ID: 23065795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C18 ceramide analysis in mammalian cells employing reversed-phase high-performance liquid chromatography tandem mass spectrometry.
    Haynes TA; Duerksen-Hughes PJ; Filippova M; Filippov V; Zhang K
    Anal Biochem; 2008 Jul; 378(1):80-6. PubMed ID: 18423390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
    Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
    Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceramide Signaling and p53 Pathways.
    Jeffries KA; Krupenko NI
    Adv Cancer Res; 2018; 140():191-215. PubMed ID: 30060809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A liquid chromatography/tandem mass spectrometry method for measuring the in vivo incorporation of plasma free fatty acids into intramyocellular ceramides in humans.
    Blachnio-Zabielska AU; Persson XM; Koutsari C; Zabielski P; Jensen MD
    Rapid Commun Mass Spectrom; 2012 May; 26(9):1134-40. PubMed ID: 22467464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing bioactive ceramides.
    Canals D; Salamone S; Hannun YA
    Chem Phys Lipids; 2018 Nov; 216():142-151. PubMed ID: 30266560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mode of ceramide action: the alkyl chain protrusion model.
    Kronke M
    Cytokine Growth Factor Rev; 1997 Jun; 8(2):103-7. PubMed ID: 9244405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts.
    Yoo HH; Son J; Kim DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Nov; 843(2):327-33. PubMed ID: 16891163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ceramide targets in interleukin-1 and tumor necrosis factor-alpha signaling in mesangial cells.
    Pfeilschifter J; Huwiler A
    Kidney Int Suppl; 1998 Sep; 67():S34-9. PubMed ID: 9736250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.